Virtual Event
July 20, 2022
11:00 AM ETT
Superbugs: Policy Solutions to Tackle an Emerging Health Threat
Event Overview
According to the Centers for Disease Control and Prevention’s (CDC) Antibiotic Resistance Threats in the United States report, more than 2.8 million antibiotic-resistant infections occur in the U.S. each year, and at least 35,000 people die as a result of these “superbugs.”
A robust pipeline of novel antimicrobial medicines is necessary for treatments to keep pace with evolving pathogens. With support from Congress, legislation can incentivize researchers to develop new antimicrobial treatments for infections for which there is an unmet medical need, anticipated clinical need, or drug resistance.
Join CQ Roll Call and Pfizer to discuss:
- Patient disease and antimicrobial resistance research
- The PASTEUR Act
- Opportunities to reduce market failures in producing critical antimicrobials
Watch Here
AGENDA
11:00 AM
Welcome Remarks
Josh Resnik, Publisher, CQ and Roll Call, President & COO, FiscalNote
11:03 AM
Policymaker Perspective
Sen. Todd Young (R-IN), Co-Sponsor, Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act
In conversation with Dr. Michelle McMurry-Heath, President and CEO, Biotechnology Innovation Organization
11:15 AM
Remarks by Sen. Michael Bennet (D-CO), Co-Sponsor, Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act
11:18 AM
Patient and Expert Panel
Thomas Heymann, President & CEO, Sepsis Alliance
Dr. Helen Boucher, MD, FACP, FIDSA; Dean ad interim & Professor of Medicine, Tufts University School of Medicine; Chief Academic Officer, Tufts Medicine
In conversation with Jessica Wehrman, Health Policy Editor, CQ Roll Call
11:45 AM
1:1 Pfizer Policy Expert Fireside Chat
Patrick Holmes, Science and Innovation Policy Team Lead, Global Policy and Public Affairs, Pfizer
In conversation with Josh Resnik, Publisher, CQ and Roll Call, President & COO, FiscalNote
11:57 AM
Closing Remarks
Josh Resnik, Publisher, CQ and Roll Call, President & COO, FiscalNote
Featured Speakers
Sen. Todd Young (R-IN)
Co-Sponsor, Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act
Sen. Michael Bennet (D-CO)
Co-Sponsor, Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act
Dr. Michelle McMurry-Heath
President and CEO, Biotechnology Innovation Organization (BIO)
Thomas Heymann
President & CEO, Sepsis Alliance
Dr. Helen Boucher
MD, FACP, FIDSA; Dean ad interim & Professor of Medicine, Tufts University School of Medicine; Chief Academic Officer, Tufts Medicine
Jessica Wehrman
Health Policy Editor, CQ Roll Call
Patrick Holmes
Science and Innovation Policy Team Lead, Global Policy and Public Affairs, Pfizer Inc.
Josh Resnik
Publisher, CQ and Roll Call, President & COO, FiscalNote
Virtual Event
July 20, 2022
11:00 AM ET